Toxicogenomics

Toxicogenomics is defined as the study of the structure and function of the genome and its responds to adverse xenobiotic exposure. It is the toxicological subdiscipline of pharmacogenomics, which is broadly defined as the study of inter-individual variations in whole-genome or candidate gene single-nucleotide polymorphism maps, haplotype markers, and alterations in gene expression that might correlate with drug responses.

  • Toxicogenomics in regulatory application
  • SAR/QSAR models
  • Screening tools to predict toxicity & targets
  • Signature/biomarker qualification
  • Bioinformatics and interpretive challenges in toxicogenomics
  • Challenges of conventional toxicology approaches
  • Toxicogenomics as a predictive tool
  • Identifying critical targets or pathways
  • Gene cloning
  • Use of toxicogenomics information directly as a POD

Related Conference of Toxicogenomics

July 02-04, 2018

15th Euro-Global Summit on Toxicology and Applied Pharmacology

Golden Tulip Berlin – Hotel Hamburg | Berlin, Germany
October 04-05, 2018 London, UK

16th Annual Meeting on Environmental Toxicology and Biological Systems

| Park Inn by Radisson Hotel
October 15-16, 2018

16th Global Summit on Toxicology and Applied Pharmacology

Las Vegas, Nevada, USA
October 22-24, 2018

17th Global Toxicology and Risk Assessment Conference

Budapest, Hungary
November 08-09, 2018

Global Summit on Toxicology and Forensic Science

Auckland, New Zealand
December 13-14, 2018

19th Annual Conference on Inhalation Toxicology

Dubai, UAE

Toxicogenomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in